Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.98 USD | -2.04% | -6.89% | -40.10% |
Apr. 25 | Truist Securities Cuts Sage Therapeutics' Price Target to $18 From $22, Hold Rating Maintained | MT |
Apr. 25 | Transcript : Sage Therapeutics, Inc., Q1 2024 Earnings Call, Apr 25, 2024 |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
781M | - | |||||
107B | ||||||
106B | ||||||
23.47B | - | |||||
21.9B | - | |||||
18.77B |